Media

Ottawa, ON /Business Wire/ December 16, 2020 / — Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Company”) today reported its audited financial results for the fiscal year ended October 31, 2020. Unless otherwise noted, all figures are in Canadian currency. “By all measures, Avivagen achieved considerable regulatory, customer, corporate and financial success in 2020,” said …Read More

Ottawa, ON /Business Wire/ November 25, 2020 / Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, announces that given the recent significant ramp up in …Read More

Ottawa, ON /Business Wire/ November 13, 2020 / Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”   or the “Corporation”),a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune   function, thereby supporting general health and performance, announces that it will be requesting approval from …Read More

Ottawa, ON /Business Wire/ October 15, 2020 / Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, announces that given the recent significant ramp up in …Read More

Four tonne order is the largest one-time purchase in Avivagen’s history, and follows UNAHCO’s three tonne order in April of this year, a previous record order Order comprised of two separate two tonne shipments that demonstrate UNAHCO’S expanded use of OxC-betaTM throughout the region. Ottawa, ON / Business Wire/ October 13, 2020 / – Avivagen …Read More